mRNA Cancer Vaccines And Therapeutics Industry Growth Expected to Reach $131.99 Billion by 2029 at a CAGR of 16.4% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the mRNA Cancer Vaccines And Therapeutics Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for mRNA cancer vaccines and therapeutics has experienced swift expansion in the past years. The market worth, set at $61.52 billion in 2024, is projected to increase to $71.85 billion in 2025, reflecting a compound annual growth rate (CAGR) of 16.8%. Factors contributing to this historical growth are lifestyle changes, financial backing, conducive regulatory conditions, robust healthcare infrastructure, and heightened developments in the product pipeline.
What Is the Forecast for the mRNA Cancer Vaccines And Therapeutics Market Size Through 2029?
Predictions suggest a speedy expansion in the market of mRNA cancer vaccines and therapeutics in the upcoming years, with an anticipated worth of $131.99 billion by 2029, showing a compound annual growth rate (CAGR) of 16.4%. This projected growth during the forecast period is due to factors like positive results from clinical trials, growing understanding and acceptance of mRNA technology, unfulfilled needs in cancer therapy, potential for enhanced patient outcomes, and the prospect of off-the-shelf availability. The forecast period is likely to see the market trend towards expansion into new therapeutic areas, taking a personalized medicine approach, advancements in mRNA delivery mechanisms, development of multivalent mRNA vaccines, and the application of artificial intelligence and machine learning in mRNA design.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
What are the Key Market Players in mRNA Cancer Vaccines And Therapeutics Market and How They’re Evolving?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
What Are the Primary Growth Drivers in the mRNA Cancer Vaccines And Therapeutics Market?
As cancer prevalence increases, so does the growth of the mRNA cancer vaccine and therapeutic market. Primarily, cancer is a wide-ranging term for diseases defined by uncontrolled growth and spread of abnormal cells that infiltrate and annihilate regular body tissue. The increase in cancer rates stems from sedentary lifestyles, unhealthy dietary habits, and exposure to environmental toxins. mRNA cancer vaccines and therapeutics become imperative for cancer, as they provide tailored, targeted treatments that boost the immune system’s power to identify and combat cancerous cells, thereby enhancing the efficacy of treatment and patient results. For example, in January 2023, data released by the American Cancer Society, a US-based not-for-profit organization, working towards cancer eradication, the projected number of new cancer cases in the United States, escalated from approximately 1,918,030 in 2022 to 1,958,310 in 2023. Breast cancer remains the primary chronic condition in the United States, with cases rising from 287,850 in 2022 to 297,790 in 2023. The growing prevalence of cancer, therefore, fuels the growth of the mRNA cancer vaccine and therapeutics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp
What Are the Leading Segments in the Global mRNA Cancer Vaccines And Therapeutics Industry?
The mRNA cancer vaccines and therapeutics market covered in this report is segmented –
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
What Are the Key Market Trends in the mRNA Cancer Vaccines And Therapeutics Industry?
Key players in the mRNA cancer vaccine and therapeutics market are prioritizing the creation of innovative solutions like mRNA cancer vaccines to boost efficacy, improve patient results, and meet the increasing need for effective cancer treatments. mRNA cancer vaccines represent a kind of immunotherapy that employs messenger RNA to direct cells to generate specific antigens, subsequently activating the immune system to identify and combat cancer cells. For example, in May 2024, the FDA gave the green light to WestGene Biopharma, a biotech company based in China, to explore a new drug application for its mRNA therapeutic cancer vaccine, WGc-043. The FDA’s clearance of WGc-043 signifies a significant advance in the treatment of advanced EB virus-related cancers, strongly associated with more than ten malignancies such as nasopharyngeal carcinoma, NK T-cell lymphoma, and several varieties of cancer including gastric, lung, liver, esophageal, breast, and cervical, as well as autoimmune diseases like multiple sclerosis and lupus.
Access The Full Report Here:
What Is the Regional Outlook for the mRNA Cancer Vaccines And Therapeutics Market?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17204
This Report Delivers Insight On:
1. How big is the mrna cancer vaccines and therapeutics market, and how is it changing globally?
2. Who are the major companies in the mrna cancer vaccines and therapeutics market, and how are they performing?
3. What are the key opportunities and risks in the mrna cancer vaccines and therapeutics market right now?
4. Which products or customer segments are growing the most in the mrna cancer vaccines and therapeutics market?
5. What factors are helping or slowing down the growth of the mrna cancer vaccines and therapeutics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
